Fatigue in multiple sclerosis
- PMID: 11898532
- DOI: 10.1007/s11910-001-0033-7
Fatigue in multiple sclerosis
Abstract
Fatigue is among the most common, yet least understood, symptoms of multiple sclerosis (MS) [1.]. It can profoundly disrupt the occupational and social functioning of patients, and is recognized as a criterion for MS disability by the Social Security Administration. Most approaches to fatigue assessment can be classified as either self-report scales or performance-based measures of motor or cognitive output. During the clinical management of fatigue, it is important to consider the role of other MS symptoms on fatigue, as well as that of non-MS-related medical conditions. Management of fatigue in MS often entails both pharmacologic and behavioral components. This article reviews recent developments in the assessment, treatment, and pathogenesis of MS fatigue.
Similar articles
-
Fatigue in multiple sclerosis - a brief review.J Neurol Sci. 2012 Dec 15;323(1-2):9-15. doi: 10.1016/j.jns.2012.08.007. Epub 2012 Aug 27. J Neurol Sci. 2012. PMID: 22935407 Review.
-
Treating fatigue in patients with MS: one step forward, one step back.Neurology. 2005 Apr 12;64(7):1111-2. doi: 10.1212/01.WNL.0000159518.42481.5A. Neurology. 2005. PMID: 15824329 No abstract available.
-
Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.Contemp Clin Trials. 2018 Jan;64:67-76. doi: 10.1016/j.cct.2017.11.005. Epub 2017 Nov 4. Contemp Clin Trials. 2018. PMID: 29113955 Clinical Trial.
-
Fatigue associated with multiple sclerosis: diagnosis, impact and management.Mult Scler. 2003 Jun;9(3):219-27. doi: 10.1191/1352458503ms904oa. Mult Scler. 2003. PMID: 12814166 Review.
-
Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.Neurology. 1995 Nov;45(11):1956-61. doi: 10.1212/wnl.45.11.1956. Neurology. 1995. PMID: 7501140 Clinical Trial.
Cited by
-
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.J Neurosci Nurs. 2016 Jun;48(3):143-50. doi: 10.1097/JNN.0000000000000208. J Neurosci Nurs. 2016. PMID: 27136408 Free PMC article.
-
A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.PLoS One. 2015 Dec 22;10(12):e0143970. doi: 10.1371/journal.pone.0143970. eCollection 2015. PLoS One. 2015. PMID: 26694930 Free PMC article.
-
Effect of Rehabilitation on Fatigue Level in Patients with Multiple Sclerosis.Med Sci Monit. 2018 Aug 18;24:5761-5770. doi: 10.12659/MSM.909183. Med Sci Monit. 2018. PMID: 30120829 Free PMC article.
-
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.BMC Public Health. 2013 Mar 15;13:224. doi: 10.1186/1471-2458-13-224. BMC Public Health. 2013. PMID: 23497281 Free PMC article.
-
Autonomic dysfunction in multiple sclerosis.J Neurol. 2006 Feb;253 Suppl 1:I3-9. doi: 10.1007/s00415-006-1102-2. J Neurol. 2006. PMID: 16477484 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical